SEXUAL RISK BEHAVIOR AMONG INJECTION DRUG-USING HUMAN-IMMUNODEFICIENCY-VIRUS POSITIVE CLIENTS

This study examined sexual risk behavior of 154 seropositive Hispanic injection drug-using clients who were a subsample of a larger study. T he results revealed that while nearly 71% followed safe sex practices at a 6-month follow-up, the other 29% were following risky sexual beha viors. Among males who were 25 years of age or younger, slightly over 58% were practicing unsafe sex. Among females, those in the 31-35 age group were all following risky sexual behaviors. Generally, those who lived with their sexual partners, females, and younger clients tended to follow risky sexual behaviors. These findings are very significant in the light of the heterosexual transmission of Human Immunodeficienc y Virus (HIV). Educational and case management programs are needed to provide such clients with an understanding of the possibility of HIV t ransmission to their sexual partners and to their children in case of pregnancies.